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Rift Valley fever virus (RVFV) is an arthropod-borne viral pathogen that causes significant
morbidity and mortality in small ruminants throughout Africa and the Middle East. Due to
the sporadic and explosive nature of RVF outbreaks, vaccination has proved challenging
to reduce RVFV infection in the ruminant population. Currently, there are two available
types of vaccines, live and killed, in endemic areas. In this study, two mathematical
models have been developed to explore the impact of live and killed vaccines on the
transmission dynamics of RVFV.We demonstrate in general that vaccination helps reduce
the severity of RVF outbreaks and that less delay in implementation and more vaccination
attempts and effective vaccines can reduce the outbreak magnitude and the endemic
number of RVFV. However, an introduction of a number of ruminants vaccinated by live
vaccines in RVFV-free areas may cause an outbreak and RVFV may become endemic if
there is sustained use of live vaccines. Other factors that are the important determinants
of RVF outbreaks include: unsustained vaccination programs, recruitment of susceptible
ruminants, and the seasonal abundance of mosquitoes.
Keywords: Rift Valley fever, transmission dynamics, live vaccine, killed vaccine, seasonality forces
1. INTRODUCTION
Rift Valley fever virus (RVFV) is an arthropod-borne viral pathogen belonging to the Phlebovirus
genus in the Bunyaviridae family. It has been known to have a considerable effect on domesticated
animals and humans in Africa and the Middle East. The virus was first detected in 1930 in Kenya. It
was initially confined to Africa and Egypt, but later moved into the Middle East in 2000 (Abdo-
Salem et al., 2011b). Infection with RVFV in animals is often associated with bloody diarrhea,
necrotic hepatitis, hemorrhages, and abortions. Mortality due to the infection in some species of
ruminants is nearly 100% in young animals and approximately 20–30% in adults (Evans et al.,
2008; McElroy et al., 2009). In addition, the abortion rate of pregnant ruminants ranges from 40 to
100% during an outbreak. Susceptibility of ruminants to RVFV infection varies among species of
ruminants, breeds, ages, and viral strains; for example, sheep are more susceptible than cattle while
infected camels have as low as 2%mortality rate and only occasional abortions (Munyua et al., 2010;
Smith et al., 2010). Humans infected with RVFV typically experience mild symptoms including
fever, myalgia, and headache. However, 1–3% of these cases may develop severe encephalitis, renal
failure, fatal hepatitis, and hemorrhagic fever (Näslund et al., 2009; Smith et al., 2010).
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Transmission of RVFV among ruminants is primarily by
vectors. Numerous species of mosquitoes are able to transmit
RVFV but Aedes and Culex are considered the main vectors
(Fontenille et al., 1998; Abdo-Salem et al., 2011b). Humans
can become infected with RVFV by mosquito bites or by
contact with or inhalation of aerosols during the handling or
slaughtering of infected ruminants. RVF outbreaks are normally
sporadic [outbreaks occur between 10 and 15 years or between
3 and 5 years in some endemic areas (Andriamandimby et al.,
2010; Nderitu et al., 2011)]. Outbreaks are often linked to
the coincidence of heavy rainfall and flooding events that
allow large numbers of mosquitoes to emerge, the presence of
susceptible livestock, along with the presence of RVFV (El-Rahim
et al., 1999). RVFV is associated with two distinct transmission
cycles: low-level enzootic and epizootic (Hollidge et al., 2010).
During enzootic periods when there is non-excessive rainfall
in East Africa, it is believed that RVFV is maintained through
vertical transovarial transmission of floodwater Aedes species
especially in areas with shallow depression habitats or dambos
(Linthicum et al., 1985, 1999). High viremia caused by infected
Aedes mosquitoes that emerge from flooding events in infected
ruminants may allow the spillover of RVFV to secondary vectors
such as Culex or Anopheles mosquitoes (Bird, 2012). However,
vertical transovarial transmission is not currently present in the
Middle East and West Africa. Factors associated with epizootics
in West Africa and high rain forest zones of coastal and Central
Africa remain unknown (El-Rahim et al., 1999; Martin et al.,
2008).
Because of the high number of competent vectors of RVFV,
the intensification of international trade of live animals that
may introduce infected ruminants into non-endemic areas
with high densities of susceptible livestock, and the unknown
impact of climate change, several national and international
agencies have issued warnings of the heightened risk of RVFV
introduction (Ikegami and Makino, 2009; Pepin et al., 2010).
Typically, preventive measures to control the spread of RVFV
include disease surveillance, strategic vaccination of livestock,
intensive vector control, restriction of animal movement, bans on
animal importation from RVF-endemic countries, and increase
of public awareness (Al-Afaleq and Hussein, 2011). Due to the
severity of economic consequences from RVF outbreaks, routine
immunization of lambs and calves is recommended. However, it
is prohibitively expensive in Africa and sustaining vaccination
programs in ruminants between outbreaks has proved difficult
(Rusnak et al., 2011). Currently, two types of vaccines are
available in endemic areas for the prophylactic immunization of
ruminants (von Teichman et al., 2011).
Live attenuated RVFV vaccines (or live vaccines) provide
long-term protective immunity without booster inoculations
and are inexpensive to produce. The vaccines were developed
from the Smithburn strain of RVFV by serial passages in
mouse brains (Smithburn, 1949; Ikegami and Makino, 2009).
As the neuroadapted virus only partially lost its virulence, this
vaccine may induce abortions and teratogenesis in pregnant
ruminants, and has the potential for reversion and capability
to cause viraemia. Mosquitoes feeding on vaccinated ruminants
may become infected and transmit RVFV to other ruminants
and humans (Ikegami and Makino, 2009; Pepin et al., 2010;
Kamal, 2011). Consequently, live vaccines are restricted and only
used during devastating outbreaks. They should not be used in
pregnant and young ruminants, and are not recommended in
countries where RVFV has not been introduced. Moreover, the
vaccines should not be administered to animals during breeding
seasons of mosquitoes. According to vaccine description, animals
used for human consumption should not be slaughtered
within 21 days after vaccination. Used syringes, needles and
remaining vaccine in bottles should be disposed hygienically
(Kamal, 2011).
Formalin-inactivated RVFV vaccines (or killed vaccines) can
be administered to animals of all ages and are safer than live
vaccines. However, they are not as efficacious as live vaccines
and thus repeated inoculations are required to induce and
maintain protective immunity since an initial dose may only
immunize a ruminant only for 6–12 months (Ikegami and
Makino, 2009). Because these vaccines consist of relatively
concentrated suspensions of the virulent virus that have been
inactivated by formaldehyde or other chemical substances, they
would be suitable for non-endemic areas and animals exported
from endemic to RVFV-free areas (Wolrld Health Organization,
1982; von Teichman et al., 2011). Although killed vaccines have
advantages of safety, they are costly to produce (Wolrld Health
Organization, 1982).
Clearly, the use of live and killed vaccines to control the spread
of RVFV is hampered by their disadvantages and highly effective
vaccines are needed. New generation vaccines are currently under
development and under clinical trials: (1) the attenuated MP12
which is derived from the virulent Egyptian strain (ZH548) and
a plaque isolate of RVFV 74HB59, and (2) Clone 13 which
is an avirulent candidate with no reversion owing to a large
deletion in the NSs protein (that has been pointed out to
be a virulence factor in animals), for instance (Ikegami and
Makino, 2009; Pepin et al., 2010; Rusnak et al., 2011). Virus-like
particle (VLP) approach and immunization with plasmids are
examples of alternative approaches to develop vaccines (Ikegami
and Makino, 2009; LaBeaud, 2010). Effective vaccines surely will
facilitate the preparedness for prevention of an introduction of
RVFV to disease-free areas and help reduce economic losses
from dead and aborted ruminants. The ideal vaccine would be
one that is safe without causing any pathogenic reaction and
virulence reversion and confers long-term protection within a
single dose. In addition, it should provide the differentiability
between naturally infected and vaccinated animals (DIVA), and
should not be expensive and difficult to produce (LaBeaud, 2010).
Although vaccines can induce immunity against RVFV, it is
important to recognize that recombination of live vaccinal strains
and virulent strains is possible. Vaccines with deleted genes can
reobtain those missing genes and cause serious consequences for
disease elimination (Kamal, 2011).
Many modeling tools have been used to explore the risk
of recurrent outbreaks in the endemic areas and the risk of
RVF introduction in disease-free areas: climatic indices, spatial
techniques, multi-variable statistical analysis, and dynamical
transmission models (see Métras et al., 2011 for a review).
Though there are some studies using dynamical transmission
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models (Bicout and Sabatier, 2004; Favier et al., 2006; Gaff
et al., 2007; Mpeshe et al., 2011; Xue et al., 2012; Gao et al.,
2013; Chamchod et al., 2014; Xiao et al., 2015), to the best
of our knowledge, none of these papers has addressed the
use of live and killed vaccines which is a clearly important
and currently used means to control RVF epizootics and
enzootics. For example, Bicout and Sabatier (2004) developed
a stochastic model to investigate the prevalence of RVFV
by including the seasonal abundance of mosquitoes. Favier
et al. (2006) studied the endemicity of RVFV through vertical
transmission in mosquitoes. In 2007, Gaff et al. (2007) developed
a mathematical model by considering two species of mosquitoes.
Apart from mosquito and livestock population, Mpeshe et al.
(2011) incorporated a human population to investigate the
prevalence of RVFV. In this study, we now develop two
mathematical models to investigate the transmission dynamics
of RVFV and the impacts of using live or killed vaccines. These
two new models that capture advantages and disadvantages of
live and killed vaccines incorporate several factors that may
influence RVFV activity such as delay in vaccination, efficacy
of vaccines, recruitment of animals, quarantine strategies, the
abundance of mosquitoes, and vaccination strategies, in order to
explore severity of RVF outbreaks, the prevalence of RVFV, the
recurrence of outbreaks and the virus introduction. Our study
provides an important insight into the effects of implementation
of live or killed vaccines as an RVF control measure and
underlines the need for effective vaccines. Our approach can also
possibly be applied to explore certain diseases for which live or
killed vaccines are used as preventive tools. West Nile virus, in
which a number of candidates for live and killed vaccines are
currently in various stages of testing, is a possible example (Tesh
et al., 2002).
2. METHODS
We begin by introducing vaccination models for live and killed
vaccines. A ruminant population at time t (N(t)) is divided
into classes of susceptible (S(t)), infectious (I(t)), recovered
(R(t)) and vaccinated by live vaccines (V1(t)) or vaccinated by
killed vaccines (V2(t)) ruminants. A population of adult female
mosquitoes at time t (M(t)) is divided into susceptible (U(t))
and infectious (W(t)) classes. Flow diagrams for both models are
shown in Figure 1 and sample parameter values are shown in
Table 1. To construct themodels, we now lay out the assumptions
for each type of vaccine.
2.1. Live Vaccines
2.1.1. Host Demography
Susceptible numbers of ruminants are increased by births at
a rate 3r(S, I,R,V1). We further assume that due to limited
resources or human demands and abortions of ruminants from
RVFV, 3r is described by the logistic term (b − qN)(S +
R) + r1(b − qN)I + r2(b − qN)V1, where b is the birth rate
of ruminants; q is a parameter reflecting the limited number
of ruminants in an area; r1 is a proportion of surviving
newborns from infected ruminants [since RVF infection can
cause high abortion in pregnant ruminants (McElroy et al.,
2009)]; and r2 is a proportion of surviving newborns from
ruminants vaccinated with live vaccines [as live vaccines can
cause abortion in early-stage pregnant ruminants (Kamal, 2011)].
Ruminant numbers decrease due to natural death and slaughter
at a rate µ. RVF infection causes high mortality in ruminants
(Evans et al., 2008) and only some animals recover with life-
long immunity (Barnard, 1979; Paweska et al., 2005). Hence,
ruminants die due to RVFV at a rate d and recover at a
rate γ .
2.1.2. Vector Demography
We assume that mosquitoes die at a rate η and there is no vertical
transovarial transmission so that mosquitoes are born disease-
free at a rate3m which is described by a logistic term (g−xM)M,
where g is the birth rate of mosquitoes and x is a crowding
parameter for mosquitoes. Note that vertical transmission is
present in East Africa but not currently present in theMiddle East
andWest Africa (El-Rahim et al., 1999; Martin et al., 2008). Since
we are primarily interested in understanding the effects of RVF
on ruminant populations and how those effects are influenced by
the use of vaccines, we do not include vertical transmission in our
study.
2.1.3. Live Vaccines
Although live vaccines induce early and long-term immunity,
they may cause viraemia in ruminants and have a potential for
virulence reversion. Hence, they are not recommended in non-
endemic areas or during the breeding season of mosquitoes or
during disease outbreaks (Ikegami and Makino, 2009; Kamal,
2011). Susceptible ruminants are vaccinated at a rate ρ11φ1,
where 1/φ1 is the time period that ruminants remain susceptible
before being vaccinated and only a fraction ρ11 of ruminants is
actually vaccinated. Vaccinated ruminants leave the vaccination
class at a rate λ with a probability of ρ12 to successfully acquire
a life-long immunity, a probability of ρ13 that reversion to
virulence occurs, and a probability of 1 − ρ12 − ρ13 for vaccine
failure.
2.1.4. Transmission
Susceptible ruminants become infected at a rate βWS, where
β is a per capita transmission rate from infectious mosquitoes
to susceptible ruminants and it is a function of a per capita
biting rate (a) and a probability of successful infection in
ruminants (pr). Susceptible mosquitoes become infected from
biting infectious ruminants at a rate αUI, where α is a per
capita transmission rate from infectious ruminants to susceptible
mosquitoes and it is a function of a per capita biting rate (a) and
a probability of successful infection in mosquitoes (pm). Here, we
assume that ruminants vaccinated by live vaccines can transmit
RVFV to mosquitoes due to viraemia but the transmission
is reduced by a factor δ from the rate of transmission from
infectious ruminants. If δ = 1, there is no viraemia in
vaccinated ruminants and if δ = 0, there is no reduction
of viraemia in vaccinated ruminants as compared to infectious
ruminants.
The changes in abundances of ruminants and mosquitoes
over time can be described by a system of ordinary differential
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FIGURE 1 | Flow diagrams. Flow diagrams for RVFV transmission between ruminants and mosquitoes for live and killed vaccines are shown in (A,B), respectively.
Ruminants are divided into four classes: susceptible (S), infectious (I), recovered (R), and vaccinated by live vaccines (V1 ) or killed vaccines (V2 ). Mosquitoes are
divided into two classes: susceptible (U) and infectious (W).
equations as follows:
S˙(t) = 3r(S, I,R,V1)+ (1− ρ12 − ρ13)λV1 − βWS
−ρ11φ1S− µS,
I˙(t) = βWS+ ρ13λV1 − (µ+ d + γ )I,
R˙(t) = γ I + ρ12λV1 − µR,
V˙1(t) = ρ11φ1S− (µ+ λ)V1,
U˙(t) = 3m(M)− αIU − (1− δ)αV1U − ηU,
W˙(t) = αIU + (1− δ)αV1U − ηW.
(1)
Note that because the lifespan of ruminants and the lifespan of
Aedes mosquitoes, which are important vectors of RVFV, are
longer than the incubation period of RVFV, we simplify the
models by not including the exposed classes in both animals.
2.2. Killed Vaccines
2.2.1. Host Demography
As killed vaccines are safe and do not lead to abortions in
ruminants (Ikegami and Makino, 2009; Kamal, 2011), we assume
that3r is described by the logistic term (b− qN)(S+ R+ V2)+
r1(b− qN)I.
2.2.2. Vector Demography.
We use similar assumptions as live vaccines.
2.2.3. Killed Vaccines
Although killed vaccines are safer than live vaccines, they may
have poor immunogenicity by not inducing long-term immunity
and often requiring multiple vaccination doses (Ikegami and
Makino, 2009; Bird, 2012).We assume that susceptible ruminants
are vaccinated at rate ρ21φ2, where 1/φ2 is the time period
that ruminants remain susceptible before being vaccinated by
killed vaccine and only a fraction ρ21 of ruminants is actually
vaccinated. Vaccinated ruminants leave the vaccination class at
rate ν with a probability of ρ22 to receive booster vaccines and
successfully acquire long-term immunity, and a probability of
1−ρ22 for individuals to become susceptible again due to vaccine
failure or not receiving booster vaccines.
2.2.4. Transmission
Not only susceptible ruminants but also ruminants vaccinated
by killed vaccines [that may not induce complete protection
against infections due to waning of an effective level of immunity
(Boshra et al., 2011; Bird, 2012)] may become infected. However,
we assume that infectiousness in the latter group of animals
is reduced by a fraction σ , which represents the degree of
protection induced by primary vaccination. Hence, susceptible
and vaccinated ruminants become infected at rates βWS and
(1 − σ )βWV2, respectively. Note that there is full protection
against infections by killed vaccines if σ = 1 and there is no
protection if σ = 0. Unlike live vaccines, killed vaccines with
proper inactivation are not likely to cause viraemia in animals
(Bird, 2012). Hence, we assume that only infectious ruminants
can transmit RVFV to mosquitoes at rate αUI.
The assumptions lead to the following system of equations:
S˙(t) = 3r(S, I,R,V2)+ (1− ρ22)νV2 − βWS− ρ21φ2S− µS,
I˙(t) = βWS+ (1− σ )βWV2 − (µ+ d + γ )I,
R˙(t) = γ I + ρ22νV2 − µR,
V˙2(t) = ρ21φ2S− (1− σ )βWV2 − (µ+ ν)V2,
U˙(t) = 3m(M)− αIU − ηU,
W˙(t) = αIU − ηW.
(2)
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TABLE 1 | Lists of parameters for Rift Valley fever virus transmission.
Description Symbol Sample value References
Natural death rate in ruminants (year−1) µ 1/5.7-1/2 Majok et al., 1991
Birth rate in ruminants (year−1) b 2.3 Majok et al., 1991
Recovery duration (year) τ 8/365 Pepin et al., 2010
Probability of death due to RVFV in ruminants m 0.3 Evans et al., 2008
Rate of recovery in ruminants (year−1) γ (1−m)(1/τ )
RVF-related death rate in ruminants (year−1) d m(1/τ )
The maximum number of ruminants N0 100,000 Estimated
(reflecting limited resources)
Crowding parameter of ruminants q (b− µ)/N0
Proportion of surviving newborns from r1 0.6 McElroy et al., 2009
infectious ruminants
Proportion of surviving newborns from r2 0.72 Kamal, 2011
ruminants vaccinated by live vaccines
Vaccination rate (year−1) φ1, φ2 365/141 Métras et al., 2011
Probability that ruminants are vaccinated ρ11, ρ21 0–1, 0.8 Marawan et al., 2012
Probability of successfully acquiring immunity ρ12 0–1, 0.9 Niklasson et al., 1985; Papin et al., 2011
from live vaccines
Probability of reversion of virulence of ρ13 0–0.2, 0.05 Davies, 2006; Nguku et al., 2010
live vaccines
Probability of receiving a repeated dose of ρ22 0–1, 0.8 Marawan et al., 2012
killed vaccine
Duration of viraemia in ruminants vaccinated λ 21/365 Kamal, 2011
by live vaccines (year)
Duration of protection from a primary dose ν 5/12 Kamal, 2011
of killed vaccine (year)
Biting rate (year−1) a 256
Probability of successful infection in ruminants pr 0.14 Turell et al., 2008
Probability of successful infection in mosquitoes pm 0.35 Turell et al., 2008
Birth rate in mosquitoes (year−1) g 73 Dye, 1984; Hancock et al., 2009
Death rate of mosquitoes (year−1) η 365/60 Reiskind et al., 1987
Maximum mosquito:ruminant ratio at k0 0–10, 1.5 Gupta et al., 1994 (varying)
The maximum number of mosquitoes M0 k0N
0
Crowding parameter of mosquitoes x (g− η)/M0
Reduction factor of transmission from ruminants δ 0–1, 0.8 (varying)
vaccinated by live vaccines to mosquitoes
Reduction factor of transmission in ruminants σ 0–1, 0.8 (varying)
vaccinated by killed vaccines
2.3. Periodic Vaccination, Recruitment of
Animals, and Seasonal Variation
2.3.1. Periodic Vaccination
When vaccination attempts are periodic-like and not continuous,
it is assumed that
ρ11(t) = ρ21(t) =
{
0.8, i− 1 ≤ t ≤ i,
0, i ≤ t ≤ i+ 1,
where i = 1, 3, 5, · · · ,
where i represents the vaccination period (that is, a year).
This means that a contant vaccination rate (80%) is applied
throughout the first year and no vaccination in the second year,
followed by a contant vaccination in year 3 and no vaccination in
year 4, and so on.
2.3.2. Recruitment of Animals
Ruminants are often recruited to replace dead or consumed
animals in many areas. In this study, the pulse terms of animal
recruitment are incorporated into the equation of S˙ to represent




(N0 − N(t))δ(t − nT), (3)
where T is a fixed period of introduction, n = 1, 2, 3, . . ., and
δ is a Dirac delta function such that δ(t − nT) = 1 when t =
nT and δ(t − nT) = 0 elsewhere. By adding the term (N0 −
N(t))δ(t − nT) at every recruitment time, the total population
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FIGURE 2 | Live and killed vaccines. Infectious numbers of ruminants over time in case of live vaccines are shown in (A) (black trace = with no vaccination and
R0 > 1, green trace = with vaccination and R0 > 1, blue trace = with vaccination and R0 < 1, red trace = with no vaccination and R0 < 1). Infectious numbers in
case of killed vaccines are shown in (B) (red trace = with no vaccination and Rk0 > 1, blue trace = with vaccination and R
k
0 > 1, green trace = with vaccination and
Rk0 < 1). (C) Shows that the epidemic size of an outbreak decreases when the number of vaccinated ruminants at t = 0 increases and R0 > 1 for both live and killed
vaccines (red trace = live vaccines, black trace = killed vaccines). The epidemic size of an outbreak when the number of vaccinated ruminants at t = 0 varies and
R0 < 1 for live vaccines is shown in (D). (E) Shows the epidemic size of an outbreak corresponding to the delays in vaccination after an infectious ruminant is
introduced for live and killed vaccines (red and solid traces: ρ11 = 0.8, ρ12 = 1, ρ13 = 0, δ = 0.9, magenta and solid traces: ρ11 = 0.8, ρ12 = 0.9, ρ13 = 0.05,
δ = 0.8, magenta and dashed traces: ρ11 = 0.8, ρ12 = 0.8, ρ13 = 0.05, δ = 0.8, green and dashed traces: ρ21 = 0.8, ρ22 = 0.8, σ = 0.8, blue and solid traces:
ρ21 = 0.8, ρ22 = 0.8, σ = 0.8, green and solid traces: ρ21 = 0.8, ρ22 = 1, σ = 0.9 ).
always starts at N0 at each recruitment point. In case there is a
variety in recruitment, (3) can be added in other disease classes
and adjusted by multiplying it with percentages of recruited
animals to be in each disease status.
2.3.3. Seasonal Variation of Mosquitoes
To consider the effect of seasonal abundance of mosquitoes, we
assumed that the mosquito:ruminant ratio (k) fluctuates over
time as a sinusoidal function such that the mosquito:ruminant
ratio is highest at the middle of each wet season and lowest at the
middle of each dry season as follows:
k = k1(1− k2 cos 2π t),
with k2 = (kmax/kmin − 1)/(kmax/kmin + 1), k1 = kmax/(1+ k2),
and M = kN0 (Altizer et al., 2006; Childs and Boots, 2010) with
k ranging from 0.2 to 2 in our numerical study.
Note that the initial conditions unless they are varied for
our numerical studies are as follows: S(0) = 99, 995, I(0) =
5,R(0) = 0,V1(0) = 0 = V2(0),U(0) = 150, 000 and V(0) = 0.
3. RESULTS
3.1. The Basic Reproductive Number
When vaccination is not implemented, both models (1) and
(2) lead to the same basic reproductive number (R0). Without




η(µ+ d + γ )
(4)
[see Section 1 in the Supplementary Material for the derivation of
this formula and analysis of the system (1)]. From this formula,
we can see that persistence of RVFV depends on transmission
rates between ruminants and mosquitoes, numbers of ruminants
and mosquitoes, lifespan of ruminants and mosquitoes, RVF-
related death rate, and recovery rate. However, when live vaccines
are used, RVFV always persists even when R0 < 1. Hence, we
cannot find a formula for the basic reproductive number for the
live-vaccine case. The persistence of RVFV when live vaccines are
used is due to reversion to virulence and transmission during
viremia of vaccinated ruminants. Figure 2A shows that RVFV
is endemic when R0 > 1 regardless of whether vaccination is
implemented. However, when R0 < 1, RVFV dies out when there
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FIGURE 3 | The epidemic size and endemic numbers. (A) The epidemic size of an outbreak for live vaccines when the probability that ruminants are vaccinated
(ρ11 ) and the probability that they acquire immunity (ρ12 ) vary. (B) The epidemic size of an outbreak for killed vaccines when the probability that ruminants are
vaccinated (ρ21 ) and the probability that they receive repeated doses later (ρ22 ) vary. (C) The endemic number of RVFV among ruminants changes according to ρ11
and ρ12. (D) The endemic number of RVFV among ruminants changes according to ρ21 and ρ22.
is no implementation of live vaccines and it is endemic when
there is implementation.
In case killed vaccines are used in an area, RVFV dies out
if Rk0 < 1 and is endemic if R
k
0 > 1, where R
k
0 is the
basic reproductive number when killed vaccines are used and is
given by
Rk0 = R0
µ(µ+ ν)+ (1− σ )µρ21φ2
(ρ21ρ22φ2ν + ρ21φ2µ+ µ(µ+ ν))
< R0 (5)
[see Section 2 in the Supplementary Material for the derivation
of this formula and analysis of the system (2)]. Differently,
persistence of RVFV in ruminant and mosquito populations
depends on parameters associated with killed vaccines,
vaccination rate, vaccine coverage, and the probability of
receiving a repeated dose of killed vaccine. Consequently, it
may be possible to eliminate RVFV by increasing vaccination
attempts. In Figure 2B, whether killed vaccines are implemented,
RVFV is endemic when R0 > Rk0 > 1. However, by increasing
vaccination attempts so that Rk0 < 1, RVFV dies out.
Under the assumption that some ruminants are vaccinated
by live or killed vaccines before an outbreak occurs (42% of
the ruminant population for instance: this is quantity estimated
from the vaccination rate and 2 months of advance notice of
RVF activity in Table 1), the magnitude of an outbreak in our
numerical studies (which we will call the epidemic size through
the rest of this work) when live vaccines are used or ruminants
vaccinated by live vaccines are introduced in areas is higher than
when killed vaccines are used (Figures 2A,B). Note that there is
a subtle difference when vaccination is not continued after an
introduction of diseased or vaccinated ruminants. Moreover, in
Figures 2A,B, it can be clearly seen that outbreaks in areas where
killed vaccines are used occur in a later time than areas where
live vaccines are used. We further investigated the duration from
an introduction of diseased ruminants to the time that a RVF
outbreak peaks (see Section 3 in the Supplementary Material).
We found that this duration is shorter in areas where live vaccines
are administered in comparison to areas where killed vaccines are
used. This duration can be shortened by increasing the vaccine
coverage and decreasing the vaccine efficacy. In contrast, the
duration can be lengthened by increasing the probability that
ruminants are vaccinated by killed vaccines and vaccine boosters.
Hence, outbreaksmay peak in areas where live vaccines with poor
efficacy are heavily used before areas in which killed vaccines are
effectively administered.
3.2. Initial Control and Delay
From the above results, the basic reproductive number can
become a very useful measure to determine whether RVFV
can spread among the ruminant and mosquito populations,
and to investigate the severity of disease spread. The latter as
measured by the epidemic size and endemic number Brauer
and van den Driessche (2008) is an increasing function of the
basic reproductive number. Note that the epidemic size is the
maximum number of infectious ruminants during an outbreak
and the endemic number is described by the number of infectious
ruminants at the disease-present steady state. In addition, there
are several factors that influence the severity of disease spread:
the number of vaccinated ruminants at the beginning of an
outbreak and the delays in implementing a vaccination control,
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for instance. Figure 2C shows that the epidemic size is reduced
by increasing the initial number of vaccinated ruminants by live
or killed vaccines. As it cannot be easily seen in Figure 2C, we
further investigated tangent slopes that represent the changes
of epidemic sizes with respect to the changes of numbers of
ruminants vaccinated by live or killed vaccines. We found
that (1) the reduction of epidemic sizes occurs slowly when
fewer numbers of ruminants are vaccinated by live vaccines
and increases quickly when vaccinated numbers become larger,
and (2) the reduction occurs quickly when fewer numbers of
ruminants are vaccinated by killed vaccines andmoderately when
larger numbers of ruminants are vaccinated. Since ruminants
vaccinated by live vaccines may transmit RVFV to mosquitoes,
we investigated whether an outbreak occurs when ruminants are
vaccinated by live vaccines as a preparedness plan or introduced
in areas with R0 < 1 and no vaccination. Figure 2D shows
that an outbreak occurs and vaccinated numbers have a negative
impact on the epidemic size when they increase. However,
when the number of ruminants vaccinated by live vaccines is
approximately more than a half of the population size, the
epidemic size starts to decrease. In Figure 2E, when there is a
delay in vaccination by live or killed vaccines, the longer the delay
is, the larger the epidemic size gets. The epidemic size eventually
reaches the same size with when vaccination is not implemented
if the delay is sufficiently long enough (approximately 3 months).
3.3. The Epidemic Size and Endemic
Number
Next, we investigated the impact of vaccination attempts
(ρ11, ρ21, ρ22) and vaccine efficacy (ρ12) on the epidemic size
and endemic number. Figure 3A shows that the probability that
ruminants are vaccinated by live vaccines has a small effect on
the epidemic size as compared to the probability of successfully
acquiring immunity of ruminants. Both haveminute effects when
no ruminants are vaccinated by live vaccines at the beginning of
an outbreak (Section 3 in the Supplementary Material). When
some ruminants are vaccinated by killed vaccines before an
outbreak starts, the probability that ruminants are vaccinated by
killed vaccines and probability that ruminants receive repeated
doses influence the epidemic size by decreasing it. In case none
of the ruminants are vaccinated by killed vaccines before an
outbreak, the former has a greater impact than the latter when
the vaccines are administered later (Figure 3B and Section 3 in
the Supplementary Material). As shown in Figures 3C,D, all of
those vaccines quantities have an impact on the endemic number
of RVFV in ruminants. By further investigating the epidemic size
and endemic number with other vaccine efficacy terms (ρ13, δ,
and σ ), the results lead to a similar conclusion that the better
the vaccine efficacy is, the smaller the epidemic size and endemic
number are. Note that additional results not included in Figure 3
can be found in Section 3 in the Supplementary Material.
3.4. Periodic Vaccination
Because of the periodic or sporadic nature of RVF outbreaks and
economically limited access to vaccines, sustained vaccination
efforts on RVFV have proved difficult in many endemic areas.
Figures 4A,B show the number of infectious ruminants in
correspondence with the periodic vaccination of live or killed
vaccines for every two years. From the results, the periodic
vaccination efforts may cause small outbreaks in both live and
killed vaccine cases. Although the first outbreak is more serious
when live vaccines are used, it is more likely that subsequent
outbreaks are smaller than when killed vaccines are used. On the
other hand, killed vaccines have a greater impact on reducing the
severity of outbreaks if the vaccination period is lengthened as
compared to live vaccines (Figures 4C,D).
3.5. Recruitment of Animals
We investigated the introduction of new susceptible ruminants
into the ruminant population at the beginning of every year
or every three years (these periods can be adjusted to account
for the banning of imported animals by the government after
an outbreak occurs) by introducing pulse functions (3) of
animal recruitment (1) and (2). Figures 5A,B suggest that small
outbreaks occur in areas in which ruminants are recruited.
Their frequency is reduced by an extended period of animal
recruitment and their severity is decreased by implementing
vaccination (live or killed). Let us assume further that some
ruminants in the endemic areas are consumed at the end of every
year for a religious feast and a variety of new ruminants are
recruited to replace them and other dead ruminants afterward.
In Figures 5C,D, we assumed that (1) 20 or 50% of ruminants
are eaten during a feast in each year, (2) more than 80 or
50% of recruited ruminants are immune to RVFV (ruminants
are vaccinated and quarantined until they successfully acquire
immunity before the recruitment), (3) less than 1% of recruited
ruminants are infectious, and (4) other recruited ruminants are
either susceptible or vaccinated. The probability that ruminants
are in each disease status was chosen randomly in our
simulation study and only the lower bound of the percentage
of immune ruminants and upper bound of the percentage of





R(t)δ(t − n(T − ε))+ prandom≥0.8
∞∑
n=1
(N0 −N(t))δ(t − nT),
where ε → 0 (20% of immune ruminants are consumed and
more than 80% of recruited ruminants are immune), was added
into the equation for R˙. We found that RVF outbreaks are
more likely to occur when the percentage of recruited ruminants
with immunity to RVFV is reduced and when more ruminants
are consumed during the feast. The percentage of recruited
ruminants with acquired immunity has a significant impact on
both frequency and severity of outbreaks more than the number
of consumed ruminants. Moreover, outbreaks are more severe
when live vaccines are used in endemic areas (spiny peaks for live
vaccines and unpointed peaks for killed vaccines).
3.6. Mosquito Activity
It has been suggested that RVF outbreaks are often associated
with high numbers of mosquitoes. Figure 6A shows that the
mosquito:ruminant ratio has a drastic effect (as compared to
the mosquito lifespan) on the epidemic size so that a higher
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FIGURE 4 | Periodic vaccination. (A,B) Show numbers of infectious ruminants when periodic vaccination of live and killed vaccines is implemented, respectively
(red trace = no vaccination, blue trace = constant vaccination, black trace = periodic vaccination for every 1 year). (C,D) Show numbers of infectious ruminants
according to periodic vaccination of live and killed vaccines when vaccination periods change, respectively (black trace = 1-year period, red trace = 3-year period,
green trace = 5-year period).
mosquito:ruminant ratio leads to a larger epidemic size of the
outbreak. Hence, when the seasonal abundance of mosquitoes
is taken into account, after the first outbreak the number of
infectious ruminants peaks slightly after the middle of each year
that the mosquito:ruminant ratio is highest (see Figure 6B).
Next we assumed that 20% of ruminants are consumed at the
end of each year and replaced ruminants are recruited with at
least 50% of them immune to RVFV and less than 1% of them
infectious. Figure 6C shows that (1) recruiting ruminants during
the high activity instead of low activity of mosquitoes may cause
outbreaks, and (2) serious outbreaks are more likely to occur in
areas where live vaccines are administered and larger numbers of
ruminants with no immunity are recruited. In Figure 6D, small
outbreaks occur when ruminants are vaccinated by live vaccines
during seasons with high activity of mosquitoes. However, when
seasons with high activity of mosquitoes are lengthened, the
severity of those outbreaks increases and implementation of live
vaccines is recommended even during seasons with high activity
of mosquitoes. This result is not surprising because routine
and continuous vaccination is probably better than having no
vaccination.
4. DISCUSSION
We have developed two mathematical models to investigate
the transmission dynamics of RVFV among ruminants via
mosquitoes and the impacts of using live or killed vaccines
to control the spread of RVFV. Advantages and disadvantages
of live and killed vaccines were taken into account. Several
factors that may influence the severity and recurrence of RVF
outbreaks such as delay in vaccination, vaccination efforts,
vaccine efficacy, recruitment of animals, quarantine strategies,
the seasonal abundance of mosquitoes, and vaccination strategies
were considered in our study.
4.1. The Basic Reproductive Number
It has been observed in many endemic areas that the prevalence
of RVFV remains at a very low level after an outbreak: 1–3%
in certain areas of Africa during a non-epizootic period and as
low as 0.1% in Yemen (Davies et al., 1992; Rostal et al., 2010;
Abdo-Salem et al., 2011b). Similarly, our models predicted that
RVFV remains endemic at a very low level after an outbreak since
large numbers of infected ruminants become immune to RVFV.
The basic reproductive number (R0) is an important quantity in
epidemiology that has played a crucial role in disease control. It
potentially determines whether a disease can spread through a
population and is defined as the expected number of secondary
infections resulting from an introduction of a single infected
individual into a completely susceptible population. The number
of infected individuals increases if R0 > 1 and decreases if R0 < 1
(Brauer and van den Driessche, 2008). It also helps determine
persistence and severity of the disease spread as the epidemic size
and the endemic number of infected individuals are increasing
functions of it. To eliminate the parasite or reduce its severity
and burden, sustained disease control needs to be implemented
to ensure that R0 is less than one or as small as possible. Our
results demonstrate that the basic reproductive number of RVFV
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FIGURE 5 | Recruitment of ruminants. (A,B) Show the numbers of infectious ruminants corresponding to introduction of susceptible ruminants into areas where
live or killed vaccines are used, respectively (red trace = with every year recruitment and no vaccination, black trace = with every three year recruitment and no
vaccination, blue trace = with vaccination and every 3 recruitment, green trace = with vaccination and every 3 year recruitment). (C,D) Show the number of infectious
ruminants corresponding to consumption and introduction of ruminants in different disease statuses for live and killed vaccines, respectively (black trace = fewer
numbers of consumed ruminants and larger numbers of recruited ruminants with immunity, blue trace = larger numbers of consumed ruminants and recruited
ruminants with immunity, green trace = fewer numbers of consumed ruminants and recruited ruminants with immunity).
without vaccination generally depends on transmission rates
between ruminants and mosquitoes, numbers of ruminants and
mosquitoes, lifespan of ruminants, RVF-related death rate, and
recovery rate and is given by
R0 =
βαM0N0
η(µ+ d + γ )
.
In case live vaccines are constantly administered, RVFV persists
despite R0 < 1 (due to the possibility that ruminants vaccinated
by live vaccines may transmit RVFV to mosquitoes and reversion
to virulence of live vaccines in ruminants may occur) and
there is no particular formula for the basic reproductive
number that gives information of live vaccines. Contrarily, the
basic reproductive number when killed vaccines are used as a
preventive tool (Rk0) can be calculated (R
k
0 < R0) and is associated
with the killed vaccine parameters. This suggests that it may be
possible to eliminate RVFV by increasing a vaccination attempt
on killed vaccines so that Rk0 < 1. We further found that
the magnitude of an outbreak or the epidemic size when live
vaccines are used in prevention strategies is more likely to be
higher than killed vaccines under the same vaccination rate. This
may result from the possibility that vaccinated ruminants may
transmit RVFV to mosquitoes and the possibility of reversion to
virulence of live vaccines. Interestingly, the number of vaccinated
ruminants and vaccine efficacy play an important role in the
outbreak timing. The duration from an introduction of diseased
ruminants to the time that the virus activity peaks is shortened
by the larger number of ruminants vaccinated by live vaccines
and poor efficacy of live vaccines. However, it is lengthened
by increasing the number of vaccinated by killed vaccines and
repeated doses. Knowing the period over which the outbreak
extends could be useful in designing the effective mosquito
control strategies. So far our results support several studies
that suggest the use of killed vaccines in non-endemic areas
and agree with studies that suggest the persistence of RVFV in
areas that live vaccines are used owing to the contamination in
environment and transmission of RVFV from vaccinated animals
to mosquitoes (Kamal, 2009, 2011; von Teichman et al., 2011).
4.2. Initial Control and Delay
Although the basic reproductive number provides important
information for the spread of RVFV, it only gives partial
information on the severity of outbreaks (expressed via the
epidemic size) and the endemic number. The number of
vaccinated ruminants is one of the factors that plays a crucial
role in reducing the number of infected ruminants during
epizootic and enzootic cycles of RVFV. Remote sensing satellite
data of sea-surface temperatures, rainfall, and intensity of green
vegetation have been used to investigate and predict mosquito
and RVF activity (Linthicum et al., 1999). Prediction from
such information could provide a 2–6 week warning (Anyamba
et al., 2009). Our results show that the epidemic size is reduced
when more ruminants are vaccinated before an outbreak occurs.
Hence, a better advance warning of RVF outbreaks may aid the
control preparedness and provide sufficient time to vaccinate
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FIGURE 6 | Mosquito activity. (A) The epidemic size of an outbreak according to changes in the mosquito lifespan and the mosquito:ruminant ratio. (B) The number
of infectious ruminants changes according to the seasonal abundance of mosquitoes. (C) The changes in infectious numbers of ruminants relating to the yearly
introduction of ruminants with different disease statuses during high and low levels of mosquito activity for live and killed vaccines (red and solid trace= introduction of
ruminants during a low level of mosquito activity for live vaccines, red and dotted trace = introduction of ruminants during a high level of mosquito activity for live
vaccines, blue and solid trace = introduction of ruminants during a low level of mosquito activity for killed vaccines, blue and dotted trace = introduction of ruminants
during a high level of mosquito activity for killed vaccines). (D) The changes in infectious numbers relating to seasonal vaccination of live vaccines when the
mosquito:rumiant ratio peaks during a rainy season (k0 = 2) and is less abundant in other seasons (k0 = 1) (blue trace = vaccination is not implemented in a rainy
season which lasts 4 months, red trace = vaccination is implemented in a rainy season which lasts 4 months, green trace=vaccination is not implemented during a
rainy season that lasts 6 months, black trace=vaccination is not implemented in the areas).
ruminants to raise the herd immunity, and consequently reduce
the epidemic size of an outbreak. Moreover, we found that the
reduction of epidemic sizes occurs slowly when fewer ruminants
are vaccinated by live vaccines but changes dramatically when
numbers of vaccinated ruminants become larger. The reduction
occurs quickly when fewer ruminants are vaccinated by killed
vaccines and changes moderately when more ruminants are
vaccinated.
One of the surprising results obtained in our study is that
an outbreak may occur in areas where ruminants are vaccinated
by live vaccines for advance preparedness or introduced in
areas with R0 < 1. Note that in both cases there is no
further vaccination of live vaccines. The reason is that vaccinated
ruminants may transmit RVFV to mosquitoes and cause an
outbreak. Intermediate numbers of vaccinated ruminants may
lead to a more serious outbreak than when a small or large
number of ruminants are vaccinated. The results also suggest a
possible trade-off between transmission of RVFV in vaccinated
ruminants and herd immunity. Our finding supports several
studies that suggest the use of killed vaccines in non-endemic
areas (Kamal, 2009, 2011; von Teichman et al., 2011). The
early detection of RVFV activities is an important key for the
effective disease control to minimize outbreak consequences.
However, it is possible that the delays in diagnosis and reporting
infection cases may occur in several weeks or months between
the presumptive start of an outbreak and its initial detection by
public health and veterinary authorities (McElroy et al., 2009;
Bird, 2012). Consequently, such delays may lead to the delay in
launching a vaccination program.
Our results demonstrate that the delay in implementing
vaccination can lead to more serious outbreaks and that
outbreaks reach the same epidemic size with when no vaccination
is implemented if the delay is long enough. A good example
which supports this finding is a major 2006–2007 outbreak in
East Africa in which the public health community was alerted
for several months before the first confirmed human cases were
reported. Few preventive steps were started before laboratory
confirmation and there was a delay of almost 8 weeks in
the administration of vaccines and subsequently that caused a
substantial loss of humans and livestock (Anyamba et al., 2009;
Bird, 2012). In addition, our results suggest that the delay has
an effect on the epidemic size even though it is small for killed
vaccines. In the case of live vaccines, the delay has a small effect
when it is small but a larger effect when it becomes bigger.
Hence, according to our findings, RVF outbreaks in non-endemic
areas can be very drastic since there is presumably a delay in
vaccination.
4.3. The Epidemic Size and Endemic
Number
Vaccination attempts and vaccine efficacy are among the
important determinants of effective control. Imperfect vaccines
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that give incomplete protection and the loss of vaccine-induced
immunity, for instance, may not help prevent severe outbreaks
and their resurgence efficiently (Keeling and Rohani, 2007).
Our results suggest that inefficient vaccines and few vaccination
attempts may lead to the magnified epidemic size and the larger
endemic number. Furthermore, the percentage of ruminants
vaccinated by live vaccines has a small impact on the epidemic
size if the percentage of ruminants that successfully acquire
long-term immunity is small. For killed vaccines, both of
the percentage of vaccinated ruminants and the percentage of
ruminants receiving boosters have an impact on the epidemic size
and endemic number, but the former has a bigger impact when
none of ruminants are vaccinated before an outbreak. Based on
our findings, several factors also have a significant impact on the
epidemic size and endemic number so that the better efficacy
of vaccines may result in the smaller epidemic size and lower
endemic number: the probability of reversion to virulence, the
reduction factor of transmission from ruminants vaccinated by
live vaccines to mosquitoes, and the reduced factor of infection
in ruminants vaccinated by killed vaccines. Our results underline
how important vaccination attempts and vaccine efficacy are for
controlling RVFV and highlight the need of effective vaccines and
vaccination strategies.
4.4. Periodic Vaccination
Vaccination is an effective means to control the spread of RVFV
and prevent disease-related losses but has proved challenging
for RVFV due to the sporadic and explosive nature of RVF
outbreaks and limited access to vaccines (McElroy et al.,
2009). Sustaining vaccination programs for ruminants during
enzootic cycles and mass vaccination of ruminants during
ongoing epizootics are not normally possible (McElroy et al.,
2009; Rusnak et al., 2011). We investigated the consequences
of this periodic-like vaccination and found that the lack of
continuous vaccination efforts may cause small outbreaks in
endemic areas for both live and killed vaccines. Moreover, in
the long term, subsequent outbreaks are smaller when live
vaccines are used in comparison to killed vaccines. The use
of killed vaccines may be better for reducing the severity of
outbreaks when periods of using and discontinuing vaccines are
lengthened as compared to when such periods are shortened.
However, the lengths of such periods have less effects on live
vaccines.
4.5. Recruitment of Animals
Recruitment of ruminants into an area for consumption or
maintenance of the herd sizes may involve the introduction of
a massive number of susceptible ruminants. We investigated the
impact of the presence of susceptible ruminants on epizootic
and enzootic cycles and found that outbreaks may occur in
the endemic areas when susceptible ruminants are recruited.
However, the frequency of outbreaks can be reduced by the
extended period of animal recruitment and their severity can
be decreased by live or killed vaccine administration. This
finding corresponds to some studies suggesting that cattle of
owners who purchased ruminants to replace their herds following
outbreaks were significantly more antibody-positive than others
(Chevalier et al., 2011), and supports a control measure that
suggest a ban of animal importation after an outbreak (Abdo-
Salem et al., 2011b; Al-Afaleq and Hussein, 2011). In many areas,
ruminants are imported and consumed for religious festivals
(or are imported to replace dead or consumed ruminants)
(Thiongane et al., 1997; Abdo-Salem et al., 2011b; Al-Afaleq and
Hussein, 2011).
For international trade of ruminants, surveillance and
certification systems are required for exported countries in
order to minimize the risk of introduction of diseases; for
example, Ethiopia has collection and quarantine points where
ruminants are gathered, fed, treated, vaccinated, and kept
for approximately 20–30 days (Abdo-Salem et al., 2011b).
Since the importation of ruminants may involve a number
of ruminants in different disease statuses, we explored how
different percentages of immune (quarantined and vaccinated)
and susceptible (quarantined but not vaccinated) ruminants and
different percentages of animal consumption in the imported
areas in which live or killed vaccines are used influence RVF
activity.
Our results demonstrate that RVF outbreaks are more
likely to occur when the percentage of recruited ruminants
immune to RVFV is reduced and larger numbers of ruminants
are consumed. More interestingly, the percentage of recruited
ruminants with acquired immunity has a greater impact on
both frequency and severity of outbreaks in comparison to
the percentage of consumed ruminants. Further outbreaks are
more severe in areas where live vaccines are used. These
findings highlight the impact of animal recruitment and how
important it is to immunize animals. They may provide
important insights to design control strategies for importation of
animals.
4.6. Mosquito Activity
It has been observed in many studies that RVF outbreaks
are closely linked to heavy rainfall and high numbers of
mosquitoes (Linthicum et al., 1999; Anyamba et al., 2009; Bird,
2012). Furthermore, RVF virus activities often occur annually
and are associated with seasonal rainfall during non-epidemic
periods (Davies et al., 1992). Our results also show that (1) a
larger number of mosquitoes may increase the epidemic size
of an outbreak, (2) the number of mosquitoes has a higher
impact on the epidemic size than the mosquito lifespan, and
(3) RVF cases fluctuate according to the seasonal abundance
of mosquitoes (with a small delay after a peak of mosquito
numbers). Furthermore, one of the interesting results related
to mosquito activities suggest that recruiting ruminants during
a period with a high level of mosquito activity may promote
a severe outbreak and serious outbreaks are more likely to
occur in areas in which live vaccines are administered and
many ruminants with no immunity are recruited. Though the
effect of rainfall was not directly modeled and simulated in this
paper, in another study our team (Gil et al., 2016) modeled
the climate hydrology (rainfall) by using a sinusoidal carrying
capacity for mosquitoes synched to a solar period, and found
that concurrently high ruminant density and mosquito growth
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(with strong rainy season) can increase the likelihood of an RVF
epizootic.
The findings may simultaneously result from the increased
mosquito:ruminant ratio, larger numbers of susceptible
ruminants, and transmission possibility of ruminants vaccinated
by live vaccines. However, vaccination by live vaccines is
recommended if the period with a high level of mosquito
activity is annually longer than the period with a low level of
mosquito activity. All in all, our results agree with the live vaccine
description so that ruminants should not be vaccinated during
breeding seasons of mosquitoes (Kamal, 2011) and may also link
to some studies that suggest the emergence of RVF in Yemen in
2000 as the confluence of environmental conditions favorable
to mosquitoes and high densities of imported ruminants for
a religious feast (Abdo-Salem et al., 2011a). Based on our
results implementing stringent control measures in imported
ruminants during a mosquito season may help reduce the
epizootic risk.
Together with several factors that may influence RVF activity,
our models that capture advantages and disadvantages of live and
killed vaccines allow us to investigate the impact of vaccination
types on the RVFV transmission dynamics during epizootic
and enzootic periods that (to our knowledge) have not been
addressed in any previous modeling studies. Although some
assumptions aremade and there is limited information on certain
model parameters (for example, the percentage of ruminants that
receive booster vaccines was set high while it may be lower in
real events), several findings in our study correspond to previous
empirical studies while others make predictions that can be
further investigated empirically. Finally, due to the complexity
of RVF dynamics and several other factors, we did not use
our models to fit the documented data from any particular
region. However, we believe that this study may be useful in
understanding the dynamics of RVFV among ruminants in
areas in which vaccination is implemented, identifying the key
variables, helping indicate advantages and disadvantages of live
and killed vaccines, underlining the need of effective vaccines,
and providing important insights to help design effective control
strategies.
Since Aedes mosquitoes which are important vectors of RVFV
have a longer lifespan (60–90 days) in comparison to Anopheles
mosquitoes (14–30 days) that are important vectors to other
diseases suchmalaria, and the incubation of RVFV inmosquitoes
is around 2–4 days, this leads to a short period of mosquitoes
staying exposed as compared to their lifespan. The probability
that mosquitoes survive this exposed period is e−ητ , where η is
the death rate of mosquitoes and τ is the incubation period in
mosquitoes. This gives us e−1/30 which is close to 1. On one hand,
this term can be factored into the coefficient as β ′ = βe−ητ . Since
e−1/30 is approximately equal to 1, β ′ can be approximated by β .
On the other hand, amore general way tomodel the exposed class
is using a term βe−ητ S(t − τ )W(t − τ ) in the models. Since τ is
very small, the term can be possibly approximated by βS(t)W(t).
Hence, we decided to not include the exposed class explicitly in
our models since we mainly focused on modeling the effects of
live and killed vaccines on the transmission dynamics of RVFV.
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